A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703
Clinical trial NCT01982747 · COMPLETED
Trial details
- NCT number
- NCT01982747
- Sponsor
- Mologen AG
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2013-11-01
- Primary completion
- 2013-12-01
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.